SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-05-26 13:12
Tx date 2022-05-25
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$110.00
+1,000 vol
$0.11 each
1,148,837
Filed 2022-05-24 11:23
Tx date 2022-05-20
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$880.00
+8,000 vol
$0.11 each
1,147,837
Filed 2022-02-02 14:46
Tx date 2022-02-02
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,700
+20,000 vol
$0.135 each
478,000
Filed 2022-01-26 18:22
Tx date 2021-12-21
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-7,000
-7,000 vol
$1.00 each
255,000
Filed 2022-01-26 18:17
Tx date 2022-01-23
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-2,500
-5,000 vol
$0.50 each
250,000
Filed 2022-01-26 17:31
Tx date 2022-01-24
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$6,000
+100,000 vol
$0.06 each
200,000
Filed 2022-01-26 17:17
Tx date 2022-01-24
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-6,000
-100,000 vol
$0.06 each
158,500
Filed 2021-12-23 18:16
Tx date 2021-12-21
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-3,500
-3,500 vol
$1.00 each
Filed 2021-12-23 18:16
Tx date 2021-12-21
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-3,500
-3,500 vol
$1.00 each
258,500
Filed 2021-11-21 12:46
Tx date 2021-11-21
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$25,000
+250,000 vol
$0.10 each
1,139,837
Filed 2021-11-21 12:45
Tx date 2021-11-21
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Warrants
55 - Expiration of warrants
$-4,683.70
-46,837 vol
$0.10 each
0
Filed 2021-11-21 12:44
Tx date 2021-11-21
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-25,000
-250,000 vol
$0.10 each
46,837
Filed 2021-04-11 14:52
Tx date 2021-04-07
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-18,315
-49,500 vol
$0.37 each
889,837
Filed 2021-04-11 14:51
Tx date 2021-04-07
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-200.00
-500 vol
$0.40 each
939,337
Filed 2021-03-11 15:29
Tx date 2021-03-11
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$14,000
+140,000 vol
$0.10 each
939,837
Filed 2021-03-11 15:27
Tx date 2021-03-11
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-14,000
-140,000 vol
$0.10 each
296,837
Filed 2021-03-04 00:48
Tx date 2021-03-01
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-3,437.50
-12,500 vol
$0.275 each
799,837
Filed 2021-03-04 00:47
Tx date 2021-03-01
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-1,890
-7,000 vol
$0.27 each
812,337
Filed 2021-02-24 16:43
Tx date 2021-02-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$27,000
+270,000 vol
$0.10 each
819,337
Filed 2021-02-24 16:42
Tx date 2021-02-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-27,000
-270,000 vol
$0.10 each
436,837
Filed 2021-02-24 16:36
Tx date 2021-02-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-600.00
-2,000 vol
$0.30 each
549,337
Filed 2021-02-24 16:36
Tx date 2021-02-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-6,250
-25,000 vol
$0.25 each
551,337
Filed 2021-02-24 16:36
Tx date 2021-02-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-6,000
-25,000 vol
$0.24 each
576,337
Filed 2021-02-24 16:35
Tx date 2021-02-22
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-4,500
-20,000 vol
$0.225 each
601,337
Filed 2021-02-24 16:35
Tx date 2021-02-22
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-3,150
-15,000 vol
$0.21 each
621,337
Filed 2021-02-22 09:26
Tx date 2021-02-19
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-5,000
-25,000 vol
$0.20 each
636,337
Filed 2021-02-22 09:25
Tx date 2021-02-18
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-6,382.50
-34,500 vol
$0.185 each
661,337
Filed 2021-02-17 18:35
Tx date 2021-02-17
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-3,000
-20,000 vol
$0.15 each
695,837
Filed 2021-02-17 18:35
Tx date 2021-02-16
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-3,875
-25,000 vol
$0.155 each
715,837
Filed 2021-02-17 18:34
Tx date 2021-02-12
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-310.00
-2,000 vol
$0.155 each
740,837
Filed 2021-02-10 21:31
Tx date 2021-02-08
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-7,250
-50,000 vol
$0.145 each
742,837
Filed 2021-01-28 15:38
Tx date 2021-01-28
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$14,000
+140,000 vol
$0.10 each
792,837
Filed 2021-01-28 15:37
Tx date 2021-01-28
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-14,000
-140,000 vol
$0.10 each
706,837
Filed 2020-12-30 15:58
Tx date 2020-08-31
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-50,000 vol
0
Filed 2020-12-30 15:52
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
171,000
Filed 2020-12-30 15:50
Tx date 2020-12-29
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-4,000 vol
262,000
Filed 2020-01-31 21:06
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
Filed 2020-12-06 16:29
Tx date 2020-12-03
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
525,000
Filed 2020-12-06 16:23
Tx date 2020-12-02
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-1,045
-9,500 vol
$0.11 each
652,837
Filed 2020-12-06 16:23
Tx date 2020-12-01
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-7,215
-55,500 vol
$0.13 each
662,337
Filed 2020-12-06 16:23
Tx date 2020-12-01
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-5,060
-46,000 vol
$0.11 each
717,837
Filed 2020-12-03 17:53
Tx date 2020-11-26
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-150,000 vol
230,000
Filed 2020-12-03 17:51
Tx date 2020-12-03
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$27,500
+250,000 vol
$0.11 each
480,000
Filed 2020-12-03 17:47
Tx date 2020-11-26
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$9,000
+150,000 vol
$0.06 each
302,700
Filed 2020-12-03 17:12
Tx date 2020-12-03
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+400,000 vol
845,000
Filed 2020-12-03 16:59
Tx date 2020-12-03
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$11,000
+100,000 vol
$0.11 each
266,000
Filed 2020-12-03 16:57
Tx date 2020-04-06
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-3,250
-5,000 vol
$0.65 each
166,000
Filed 2020-12-03 16:41
Tx date 2020-12-03
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$11,000
+100,000 vol
$0.11 each
Filed 2020-11-29 23:10
Tx date 2020-11-27
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-330.00
-3,000 vol
$0.11 each
763,837
Filed 2020-11-29 23:10
Tx date 2020-11-26
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-1,045
-9,500 vol
$0.11 each
766,837
Filed 2020-11-29 23:10
Tx date 2020-11-25
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-55.00
-500 vol
$0.11 each
776,337
Filed 2020-11-29 23:09
Tx date 2020-11-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-1,650
-15,000 vol
$0.11 each
776,837
Filed 2020-11-20 17:54
Tx date 2020-11-17
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-4,812.50
-38,500 vol
$0.125 each
791,837
Filed 2020-11-20 17:54
Tx date 2020-11-17
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,920
-16,000 vol
$0.12 each
830,337
Filed 2020-11-20 17:53
Tx date 2020-11-17
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-55.00
-500 vol
$0.11 each
846,337
Filed 2020-11-16 16:58
Tx date 2020-11-10
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-15,000
-250,000 vol
$0.06 each
225,000
Filed 2020-11-16 16:51
Tx date 2020-11-10
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,000
+250,000 vol
$0.06 each
Filed 2020-11-16 16:50
Tx date 2020-11-10
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,000
+250,000 vol
$0.06 each
Filed 2020-11-16 16:20
Tx date 2020-11-10
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,000
+250,000 vol
$0.06 each
546,950
Filed 2020-11-06 19:48
Tx date 2020-11-06
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-15,000
-250,000 vol
$0.06 each
445,000
Filed 2020-11-06 19:44
Tx date 2020-11-06
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,000
+250,000 vol
$0.06 each
458,000
Filed 2020-11-02 11:26
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
846,837
Filed 2020-11-02 11:24
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Conation Capital Corp. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
846,837
Filed 2020-05-26 16:52
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2020-05-26 16:51
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-22 13:44
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-25 21:02
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,098,713 vol
1,098,713
Filed 2020-05-24 17:44
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,098,713 vol
Filed 2020-05-24 18:24
Tx date 2020-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
97 - Other
$4,468
+89,372 vol
$0.05 each
89,372
Filed 2020-05-24 17:44
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,098,713 vol
1,098,713
Filed 2020-05-24 17:42
Tx date 2019-01-14
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-24 17:39
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$65,922
+1,098,713 vol
$0.06 each
1,198,713
Filed 2020-05-24 17:39
Tx date 2020-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
97 - Other

+100,000 vol
Filed 2020-05-24 17:39
Tx date 2020-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
97 - Other

+100,000 vol
100,000
Filed 2020-05-24 17:37
Tx date 2019-01-14
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-22 13:44
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2020-05-22 13:43
Tx date 2020-05-22
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$6,000
+100,000 vol
$0.06 each
152,700
Filed 2020-02-13 21:54
Tx date 2020-02-13
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$240.00
+3,000 vol
$0.08 each
208,000
Filed 2020-02-07 14:38
Tx date 2020-02-05
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$975.00
+15,000 vol
$0.065 each
296,950
Filed 2020-02-07 13:26
Tx date 2020-02-05
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$97.50
+1,500 vol
$0.065 each
283,450
Filed 2020-02-07 13:26
Tx date 2020-02-05
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$97.50
+1,500 vol
$0.065 each
Filed 2020-01-31 21:06
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
171,000
Filed 2020-01-31 21:05
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
396,000
Filed 2020-01-31 21:03
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$5,000
+100,000 vol
$0.05 each
Filed 2020-01-31 21:03
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$7,500
+50,000 vol
$0.15 each
Filed 2020-01-31 21:00
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$5,000
+100,000 vol
$0.05 each
Filed 2020-01-31 20:58
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$7,500
+50,000 vol
$0.15 each
50,000
Filed 2020-01-31 20:58
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$7,500
+50,000 vol
$0.15 each
Filed 2020-01-31 20:54
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+5,000 vol
346,000
Filed 2020-01-31 20:48
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+3,500 vol
341,000
Filed 2020-01-31 20:46
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+3,500 vol
337,500
Filed 2020-01-31 20:44
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+4,000 vol
334,000
Filed 2020-01-31 20:42
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+5,000 vol
330,000
Filed 2020-01-31 20:37
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-210,000 vol
325,000
Filed 2020-01-31 20:11
Tx date 2019-08-25
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-325,000 vol
21,000
Filed 2020-01-29 12:13
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
475,000
Filed 2020-01-27 23:49
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
380,000
Filed 2020-01-27 22:09
Tx date 2020-01-27
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
695,000
Filed 2020-01-24 18:15
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
Filed 2020-01-24 18:06
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
Filed 2020-01-24 16:40
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
475,000
Filed 2020-01-24 16:40
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
Filed 2020-01-24 16:30
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,500
+250,000 vol
$0.05 each
Filed 2020-01-24 16:30
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,500
+250,000 vol
$0.05 each
Filed 2020-01-24 13:51
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
380,000
Filed 2020-01-24 13:51
Tx date 2020-01-24
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
Filed 2019-11-07 17:20
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+200,000 vol
$0.15 each
230,000
Filed 2019-11-07 17:18
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-07 17:18
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
30,000
Filed 2019-11-07 17:14
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-07 17:13
Tx date 2007-02-26
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-07 17:13
Tx date 2007-02-26
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-07 17:06
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-469,800 vol
52,700
Filed 2019-11-07 17:04
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Holder: Tracie Catalano (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-56,070 vol
6,230
Filed 2019-11-07 16:57
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-526,320 vol
-3,820
Filed 2019-11-07 16:57
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-526,320 vol
Filed 2018-12-21 19:06
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2007-02-26 13:52
Tx date 2007-02-26
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2007-02-26 13:49
Tx date 2007-02-26
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Holder: Ben Catalano (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-23 11:59
Tx date 2019-10-22
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,648
+45,600 vol
$0.08 each
281,950
Filed 2019-06-13 15:45
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+400,000 vol
445,000
Filed 2019-06-13 15:42
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-315,000 vol
35,000
Filed 2019-06-13 15:40
Tx date 2018-11-30
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-1,050,000 vol
350,000
Filed 2019-06-13 15:39
Tx date 2018-11-30
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-1,100,000 vol
Filed 2019-06-13 15:34
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-405,000 vol
45,000
Filed 2019-06-13 15:33
Tx date 2018-10-25
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-50,000 vol
450,000
Filed 2019-06-13 15:21
Tx date 2019-05-08
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,845,000 vol
205,000
Filed 2019-06-05 15:57
Tx date 2019-05-14
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+225,000 vol
225,000
Filed 2019-06-05 15:55
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 15:53
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,000
+100,000 vol
$0.10 each
236,350
Filed 2019-06-05 15:52
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
136,350
Filed 2019-06-05 15:48
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+50,000 vol
50,000
Filed 2019-06-05 15:45
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 15:44
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 15:44
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,000
+100,000 vol
$0.10 each
Filed 2019-06-05 15:42
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
53 - Grant of warrants
$7,500
+50,000 vol
$0.15 each
Filed 2019-06-05 15:37
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
53 - Grant of warrants
$7,500
+50,000 vol
$0.15 each
Filed 2019-06-05 15:33
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,000
+100,000 vol
$0.10 each
Filed 2019-06-05 15:29
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Martin John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 15:22
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$7,500
+50,000 vol
$0.15 each
50,000
Filed 2019-06-05 15:19
Tx date 2009-03-10
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 15:17
Tx date 2019-06-04
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,000
+100,000 vol
$0.10 each
100,000
Filed 2019-06-05 15:14
Tx date 2009-03-10
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-21
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Holder: Tracie Catalano (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
62,300
Filed 2018-12-21
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2018-12-21
Tx date 2018-12-20
$APC
Advanced Proteome Therapeutics Corporation
Catalano, William Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
522,500
Filed 2018-08-23
Tx date 2018-08-22
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$17,500
+350,000 vol
$0.05 each
2,050,000
Filed 2018-08-23
Tx date 2018-06-06
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-23
Tx date 2018-08-22
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$26,250
+350,000 vol
$0.075 each
1,400,000
Filed 2018-08-23
Tx date 2018-08-22
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$20,000
+400,000 vol
$0.05 each
400,000
Filed 2018-08-23
Tx date 2018-08-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$20,000
+400,000 vol
$0.05 each
1,750,000
Filed 2018-08-23
Tx date 2018-08-22
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption
$30,000
+400,000 vol
$0.075 each
400,000
Filed 2018-08-23
Tx date 2018-08-22
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$30,000
+400,000 vol
$0.075 each
1,350,000
Filed 2018-08-23
Tx date 2018-06-06
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: WJD Associates Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-19
Tx date 2018-06-19
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$60,000
+1,000,000 vol
$0.06 each
1,000,000
Filed 2018-06-14
Tx date 2018-06-06
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-14
Tx date 2018-06-06
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-14
Tx date 2018-06-06
$APC
Advanced Proteome Therapeutics Corporation
Dickie, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-05-17
Tx date 2018-05-17
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$16,500
+300,000 vol
$0.055 each
500,000
Filed 2018-05-17
Tx date 2018-05-17
$APC
Advanced Proteome Therapeutics Corporation
Garrett, John R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$16,500
+300,000 vol
$0.055 each
475,000
Filed 2018-04-20
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
1,050,000
Filed 2018-04-20
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-04-20
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,700,000
Filed 2018-04-19
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Garrett, John R.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
175,000
Filed 2018-04-19
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Garrett, John R.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-19
Tx date 2018-04-13
$APC
Advanced Proteome Therapeutics Corporation
Garrett, John R.
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-09
Tx date 2018-04-06
$APC
Advanced Proteome Therapeutics Corporation
Skinner, Thom
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$14,625
+225,000 vol
$0.065 each
350,000
Filed 2018-04-09
Tx date 2018-04-06
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,250
+50,000 vol
$0.065 each
535,000
Filed 2018-04-09
Tx date 2018-04-06
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$13,000
+200,000 vol
$0.065 each
2,700,000
Filed 2018-04-09
Tx date 2018-04-06
$APC
Advanced Proteome Therapeutics Corporation
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,000
+200,000 vol
$0.065 each
325,000
Filed 2018-04-09
Tx date 2018-04-06
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$16,250
+250,000 vol
$0.065 each
1,890,000
Filed 2017-09-29
Tx date 2017-09-28
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$12,000
+120,000 vol
$0.10 each
164,791
Filed 2017-09-29
Tx date 2017-09-28
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$120,000
+1,200,000 vol
$0.10 each
Filed 2017-09-29
Tx date 2017-09-28
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$6,000
+120,000 vol
$0.05 each
234,583
Filed 2017-09-29
Tx date 2017-09-28
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$60,000
+1,200,000 vol
$0.05 each
Filed 2017-07-12
Tx date 2017-07-10
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+41,666 vol
44,791
Filed 2017-07-12
Tx date 2017-07-10
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Warrants
57 - Exercise of rights

+3,125 vol
3,125
Filed 2017-07-12
Tx date 2015-06-02
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-12
Tx date 2017-07-10
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Rights 4 rights will entitle the holder to subscribe for 1 unit
57 - Exercise of rights
$-375.00
-25,000 vol
$0.015 each
0
Filed 2017-07-12
Tx date 2017-06-14
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Rights 4 rights will entitle the holder to subscribe for 1 unit
56 - Grant of rights

+25,000 vol
25,000
Filed 2017-07-12
Tx date 2015-06-02
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Rights 4 rights will entitle the holder to subscribe for 1 unit
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-12
Tx date 2017-07-10
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$4,999
+83,333 vol
$0.06 each
114,583
Filed 2017-07-12
Tx date 2017-07-10
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$375.00
+6,250 vol
$0.06 each
31,250
Filed 2017-06-14
Tx date 2017-06-13
$APC
Advanced Proteome Therapeutics Corporation
Skinner, Thom
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$6,250
+125,000 vol
$0.05 each
125,000
Filed 2017-06-14
Tx date 2017-06-09
$APC
Advanced Proteome Therapeutics Corporation
Skinner, Thom
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-13
Tx date 2017-06-12
$APC
Advanced Proteome Therapeutics Corporation
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-13
Tx date 2017-06-13
$APC
Advanced Proteome Therapeutics Corporation
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$6,250
+125,000 vol
$0.05 each
125,000
Filed 2017-06-13
Tx date 2017-06-12
$APC
Advanced Proteome Therapeutics Corporation
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-13
Tx date 2017-06-12
$APC
Advanced Proteome Therapeutics Corporation
Kirkconnell, Paul Andrew
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-09
Tx date 2017-02-08
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,000
+25,000 vol
$0.08 each
25,000
Filed 2017-02-09
Tx date 2015-06-02
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-07
Tx date 2017-02-06
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+1,000,000 vol
1,640,000
Filed 2017-01-26
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$12,600
+252,000 vol
$0.05 each
302,000
Filed 2017-01-26
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+50,000 vol
500,000
Filed 2017-01-26
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$12,600
+252,000 vol
$0.05 each
2,892,000
Filed 2017-01-25
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,500
+50,000 vol
$0.05 each
485,000
Filed 2017-01-24
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
2,500,000
Filed 2017-01-24
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Hayes, Gary Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+115,000 vol
650,000
Filed 2017-01-24
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+140,000 vol
640,000
Filed 2017-01-24
Tx date 2017-01-23
$APC
Advanced Proteome Therapeutics Corporation
Bellin, Jean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
650,000
Filed 2017-01-09
Tx date 2016-12-22
$APC
Advanced Proteome Therapeutics Corporation
1090573 B.C. Ltd.
2 - Subsidiary of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$200,000
+4,000,000 vol
$0.05 each
4,000,000
Filed 2017-01-09
Tx date 2016-09-23
$APC
Advanced Proteome Therapeutics Corporation
1090573 B.C. Ltd.
2 - Subsidiary of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-12-29
Tx date 2016-09-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jane Woodward (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
60,000
Filed 2016-12-29
Tx date 2016-09-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2016-12-29
Tx date 2016-09-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
450,000
Filed 2016-12-29
Tx date 2016-09-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jane Woodward (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
87,000
Filed 2016-12-29
Tx date 2016-09-23
$APC
Advanced Proteome Therapeutics Corporation
Woodward, Paul John Courtney
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,640,000
Filed 2016-10-31
Tx date 2016-10-28
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants

+600,000 vol
950,000
Filed 2016-10-31
Tx date 2016-10-28
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$30,000
+600,000 vol
$0.05 each
1,350,000
Filed 2016-05-19
Tx date 2016-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants

+350,000 vol
350,000
Filed 2016-05-19
Tx date 2007-02-23
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-19
Tx date 2016-05-19
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$35,000
+700,000 vol
$0.05 each
750,000
Filed 2016-05-19
Tx date 2016-05-19
$APC
Advanced Proteome Therapeutics Corporation
Bellin, Jean
4 - Director of Issuer
Direct Ownership
Warrants
53 - Grant of warrants

+129,000 vol
129,000
Filed 2016-05-19
Tx date 2008-12-09
$APC
Advanced Proteome Therapeutics Corporation
Bellin, Jean
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-19
Tx date 2016-05-19
$APC
Advanced Proteome Therapeutics Corporation
Bellin, Jean
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$12,900
+258,000 vol
$0.05 each
258,000
Filed 2016-05-19
Tx date 2008-12-09
$APC
Advanced Proteome Therapeutics Corporation
Bellin, Jean
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-31
Tx date 2015-12-29
$APC
Advanced Proteome Therapeutics Corporation
Phillippe, Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,000
+40,000 vol
$0.05 each
435,000
Filed 2015-12-30
Tx date 2015-12-29
$APC
Advanced Proteome Therapeutics Corporation
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
2,350,000
Filed 2015-12-30
Tx date 2015-12-29
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
500,000
Filed 2015-12-30
Tx date 2015-12-29
$APC
Advanced Proteome Therapeutics Corporation
Bellin, Jean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
525,000
Filed 2015-12-30
Tx date 2015-12-29
$APC
Advanced Proteome Therapeutics Corporation
Hayes, Gary Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
535,000
Filed 2015-06-02
Tx date 2015-06-02
$APC
Advanced Proteome Therapeutics Corporation
Chase, Randal
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
400,000